Dow Up 2.00% Nasdaq Up 1.66%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
379.01 Up 11.77(3.20%) Feb 12, 4:00PM EST
|After Hours : 379.09 Up 0.08 (0.02%) Feb 12, 5:04PM EST
Prev Close:367.24
Open:371.36
Bid:373.49 x 400
Ask:469.94 x 100
1y Target Est:523.29
Beta:1.80611
Earnings Date:May 5 - May 9 (Est.)
Day's Range:365.13 - 379.04
52wk Range:350.26 - 605.93
Volume:728,165
Avg Vol (3m):870,436
Market Cap:40.19B
P/E (ttm):68.66
EPS (ttm):5.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 3.20%40.19B
AMGNUp 2.30%109.12B

Key Statistics

Forward P/E (1 yr):23.57
P/S (ttm):9.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :12.03
Quarterly EPS Est (Mar-16) :2.65
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):1.54

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback